FRANCIS REYNOLDS Insider Trading $NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FRANCIS REYNOLDS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRANCIS REYNOLDS. FRANCIS REYNOLDS is 10% Owner in INVIVO THERAPEUTICS HOLDINGS CORP. ($NVIV).
FRANCIS REYNOLDS in INVIVO THERAPEUTICS HOLDINGS CORP.
Trading Symbol: NVIVIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of FRANCIS REYNOLDS: 10% Owner
Holdings: 9,045,920 shares
Current Value: $40,254,344
Latest Transaction: May 09 2014
$NVIV Market Capitalization: $139.34M
$NVIV Previous Close: $4.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of FRANCIS REYNOLDS in INVIVO THERAPEUTICS HOLDINGS CORP.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 09 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.20 | 12,500 | 15,000 | 9,045,920 | 9.1 M to 9 M (-0.14 %) |
May 09 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.19 | 12,500 | 14,875 | 9,058,420 | 9.1 M to 9.1 M (-0.14 %) |
May 09 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.20 | 25,000 | 30,000 | 9,070,920 | 9.1 M to 9.1 M (-0.27 %) |
May 01 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.89 | 12,500 | 23,625 | 9,120,920 | 9.1 M to 9.1 M (-0.14 %) |
May 01 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.82 | 12,500 | 22,750 | 9,133,420 | 9.1 M to 9.1 M (-0.14 %) |
May 01 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.76 | 12,500 | 22,000 | 9,145,920 | 9.2 M to 9.1 M (-0.14 %) |
May 06 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.79 | 21,200 | 37,948 | 9,083,420 | 9.1 M to 9.1 M (-0.23 %) |
May 06 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.05 | 3,800 | 7,790 | 9,095,920 | 9.1 M to 9.1 M (-0.04 %) |
May 06 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.95 | 12,500 | 24,375 | 9,108,420 | 9.1 M to 9.1 M (-0.14 %) |
Apr 25 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.51 | 12,500 | 18,875 | 9,158,420 | 9.2 M to 9.2 M (-0.14 %) |
Apr 25 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.51 | 12,500 | 18,875 | 9,170,920 | 9.2 M to 9.2 M (-0.14 %) |
Apr 25 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.52 | 12,500 | 19,000 | 9,183,420 | 9.2 M to 9.2 M (-0.14 %) |
Apr 25 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.52 | 12,500 | 19,000 | 9,195,920 | 9.2 M to 9.2 M (-0.14 %) |
Apr 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.57 | 12,500 | 19,625 | 9,208,420 | 9.2 M to 9.2 M (-0.14 %) |
Apr 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.55 | 12,500 | 19,375 | 9,220,920 | 9.2 M to 9.2 M (-0.14 %) |
Apr 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.57 | 12,500 | 19,625 | 9,233,420 | 9.2 M to 9.2 M (-0.14 %) |
Apr 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.57 | 12,500 | 19,625 | 9,245,920 | 9.3 M to 9.2 M (-0.14 %) |
Apr 15 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.62 | 12,500 | 20,250 | 9,258,420 | 9.3 M to 9.3 M (-0.13 %) |
Apr 15 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.63 | 12,500 | 20,375 | 9,270,920 | 9.3 M to 9.3 M (-0.13 %) |
Apr 15 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.64 | 12,500 | 20,500 | 9,283,420 | 9.3 M to 9.3 M (-0.13 %) |
Apr 09 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.55 | 12,500 | 19,375 | 9,295,920 | 9.3 M to 9.3 M (-0.13 %) |
Apr 09 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.62 | 12,500 | 20,250 | 9,308,420 | 9.3 M to 9.3 M (-0.13 %) |
Apr 09 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.62 | 12,500 | 20,250 | 9,320,920 | 9.3 M to 9.3 M (-0.13 %) |
Apr 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.70 | 12,500 | 21,250 | 9,333,420 | 9.3 M to 9.3 M (-0.13 %) |
Apr 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.72 | 12,500 | 21,500 | 9,345,920 | 9.4 M to 9.3 M (-0.13 %) |
Apr 03 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.68 | 12,500 | 21,000 | 9,358,420 | 9.4 M to 9.4 M (-0.13 %) |
Apr 03 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.70 | 12,500 | 21,250 | 9,370,920 | 9.4 M to 9.4 M (-0.13 %) |
Apr 03 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.74 | 12,500 | 21,750 | 9,383,420 | 9.4 M to 9.4 M (-0.13 %) |
Mar 28 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.76 | 12,500 | 22,000 | 9,398,920 | 9.4 M to 9.4 M (-0.13 %) |
Mar 28 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.75 | 12,500 | 21,875 | 9,411,420 | 9.4 M to 9.4 M (-0.13 %) |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.71 | 12,500 | 21,375 | 9,423,920 | 9.4 M to 9.4 M (-0.13 %) |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.78 | 12,500 | 22,250 | 9,436,420 | 9.4 M to 9.4 M (-0.13 %) |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.85 | 22,900 | 42,365 | 9,448,920 | 9.5 M to 9.4 M (-0.24 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.48 | 12,500 | 31,000 | 9,661,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.47 | 12,500 | 30,875 | 9,673,920 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 9,686,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.48 | 12,500 | 31,000 | 9,661,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.47 | 12,500 | 30,875 | 9,673,920 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 9,686,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.95 | 2,100 | 4,095 | 9,621,820 | 9.6 M to 9.6 M (-0.02 %) |
Mar 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.01 | 12,500 | 25,125 | 9,623,920 | 9.6 M to 9.6 M (-0.13 %) |
Mar 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.19 | 12,500 | 27,375 | 9,636,420 | 9.6 M to 9.6 M (-0.13 %) |
Mar 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.29 | 12,500 | 28,625 | 9,648,920 | 9.7 M to 9.6 M (-0.13 %) |
Mar 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.30 | 12,500 | 28,750 | 9,698,920 | 9.7 M to 9.7 M (-0.13 %) |
Mar 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.31 | 12,500 | 28,875 | 9,711,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 9,723,920 | 9.7 M to 9.7 M (-0.13 %) |
Mar 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.43 | 12,500 | 30,375 | 9,736,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.45 | 12,500 | 30,625 | 9,748,920 | 9.8 M to 9.7 M (-0.13 %) |
Mar 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.43 | 12,500 | 30,375 | 9,736,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.45 | 12,500 | 30,625 | 9,748,920 | 9.8 M to 9.7 M (-0.13 %) |
Feb 28 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.51 | 12,500 | 31,375 | 9,786,420 | 9.8 M to 9.8 M (-0.13 %) |
Feb 28 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 9,798,920 | 9.8 M to 9.8 M (-0.13 %) |
Mar 05 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.44 | 12,500 | 30,500 | 9,748,920 | 9.8 M to 9.7 M (-0.13 %) |
Mar 05 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.52 | 12,500 | 31,500 | 9,761,420 | 9.8 M to 9.8 M (-0.13 %) |
Mar 05 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.52 | 12,500 | 31,500 | 9,773,920 | 9.8 M to 9.8 M (-0.13 %) |
Feb 24 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 9,836,420 | 9.8 M to 9.8 M (-0.13 %) |
Feb 24 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 9,848,920 | 9.9 M to 9.8 M (-0.13 %) |
Feb 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.31 | 12,500 | 28,875 | 9,798,920 | 9.8 M to 9.8 M (-0.13 %) |
Feb 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.28 | 12,500 | 28,500 | 9,811,420 | 9.8 M to 9.8 M (-0.13 %) |
Feb 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.24 | 12,500 | 28,000 | 9,823,920 | 9.8 M to 9.8 M (-0.13 %) |
Feb 19 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 9,861,420 | 9.9 M to 9.9 M (-0.13 %) |
Feb 19 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.26 | 12,500 | 28,250 | 9,873,920 | 9.9 M to 9.9 M (-0.13 %) |
Feb 14 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.24 | 12,500 | 28,000 | 9,886,420 | 9.9 M to 9.9 M (-0.13 %) |
Feb 14 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 9,898,920 | 9.9 M to 9.9 M (-0.13 %) |
Feb 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.24 | 12,500 | 28,000 | 9,898,920 | 9.9 M to 9.9 M (-0.13 %) |
Feb 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.25 | 12,500 | 28,125 | 9,911,420 | 9.9 M to 9.9 M (-0.13 %) |
Feb 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.25 | 12,500 | 28,125 | 9,923,920 | 9.9 M to 9.9 M (-0.13 %) |
Feb 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 9,936,420 | 9.9 M to 9.9 M (-0.13 %) |
Feb 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 9,948,920 | 10 M to 9.9 M (-0.13 %) |
Feb 06 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.21 | 12,500 | 27,625 | 9,961,428 | 10 M to 10 M (-0.13 %) |
Feb 06 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.24 | 12,500 | 28,000 | 9,973,920 | 10 M to 10 M (-0.13 %) |
Feb 06 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.19 | 12,500 | 27,375 | 9,986,420 | 10 M to 10 M (-0.13 %) |
Jan 31 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.16 | 12,500 | 27,000 | 9,998,920 | 10 M to 10 M (-0.12 %) |
Jan 31 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.17 | 12,500 | 27,125 | 10,011,420 | 10 M to 10 M (-0.12 %) |
Jan 29 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.19 | 12,500 | 27,375 | 10,023,920 | 10 M to 10 M (-0.12 %) |
Jan 29 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.21 | 12,500 | 27,625 | 10,036,420 | 10 M to 10 M (-0.12 %) |
Jan 29 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.25 | 12,500 | 28,125 | 100,048,920 | 100.1 M to 100 M (-0.01 %) |
Jan 27 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.26 | 12,500 | 28,250 | 10,051,920 | 10.1 M to 10.1 M (-0.12 %) |
Jan 27 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,500 | 27,875 | 10,064,420 | 10.1 M to 10.1 M (-0.12 %) |
Jan 22 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 10,076,920 | 10.1 M to 10.1 M (-0.12 %) |
Jan 22 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.38 | 12,500 | 29,750 | 10,089,920 | 10.1 M to 10.1 M (-0.12 %) |
Jan 22 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.34 | 12,500 | 29,250 | 10,101,920 | 10.1 M to 10.1 M (-0.12 %) |
Jan 15 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.25 | 12,500 | 28,125 | 10,114,420 | 10.1 M to 10.1 M (-0.12 %) |
Jan 15 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.21 | 12,500 | 27,625 | 10,126,920 | 10.1 M to 10.1 M (-0.12 %) |
Jan 15 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.21 | 12,500 | 27,625 | 10,139,420 | 10.2 M to 10.1 M (-0.12 %) |
Jan 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.28 | 12,000 | 27,360 | 10,151,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.42 | 12,000 | 29,040 | 10,163,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.49 | 12,000 | 29,880 | 10,175,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.43 | 12,000 | 29,160 | 10,187,290 | 10.2 M to 10.2 M (-0.12 %) |
Jan 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.42 | 12,000 | 29,040 | 10,199,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.19 | 12,000 | 26,280 | 10,211,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 07 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.23 | 12,000 | 26,760 | 10,223,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 02 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.16 | 12,000 | 25,920 | 10,235,920 | 10.2 M to 10.2 M (-0.12 %) |
Jan 02 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.26 | 12,000 | 27,120 | 10,247,920 | 10.3 M to 10.2 M (-0.12 %) |
Jan 02 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.34 | 12,000 | 28,080 | 10,259,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 26 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.06 | 12,000 | 24,720 | 10,271,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 26 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.96 | 12,000 | 23,520 | 10,283,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 26 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.94 | 12,000 | 23,280 | 10,295,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 20 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.98 | 12,000 | 23,760 | 10,307,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 20 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.93 | 12,000 | 23,160 | 10,319,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 13 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.74 | 12,000 | 20,880 | 10,367,920 | 10.4 M to 10.4 M (-0.12 %) |
Dec 13 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.86 | 12,000 | 22,320 | 10,379,920 | 10.4 M to 10.4 M (-0.12 %) |
Dec 19 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.96 | 12,000 | 23,520 | 10,331,920 | 10.3 M to 10.3 M (-0.12 %) |
Dec 19 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.90 | 12,000 | 22,800 | 10,343,920 | 10.4 M to 10.3 M (-0.12 %) |
Dec 19 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.83 | 12,000 | 21,960 | 10,355,920 | 10.4 M to 10.4 M (-0.12 %) |
Dec 11 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.98 | 12,000 | 23,760 | 10,391,920 | 10.4 M to 10.4 M (-0.12 %) |
Dec 11 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.71 | 12,000 | 20,520 | 10,403,920 | 10.4 M to 10.4 M (-0.12 %) |
Dec 11 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.56 | 12,000 | 18,720 | 10,415,920 | 10.4 M to 10.4 M (-0.12 %) |
Dec 06 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.52 | 12,000 | 18,240 | 10,427,920 | 10.4 M to 10.4 M (-0.11 %) |
Dec 06 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.66 | 12,000 | 19,920 | 10,439,920 | 10.5 M to 10.4 M (-0.11 %) |
Dec 04 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.76 | 12,000 | 21,120 | 10,451,920 | 10.5 M to 10.5 M (-0.11 %) |
Dec 04 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.95 | 12,000 | 23,400 | 10,463,920 | 10.5 M to 10.5 M (-0.11 %) |
Dec 04 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.00 | 12,000 | 24,000 | 10,475,920 | 10.5 M to 10.5 M (-0.11 %) |
Nov 29 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.97 | 12,000 | 23,640 | 10,487,920 | 10.5 M to 10.5 M (-0.11 %) |
Nov 29 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.03 | 12,000 | 24,360 | 10,499,920 | 10.5 M to 10.5 M (-0.11 %) |
Nov 29 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.00 | 12,000 | 24,000 | 10,511,920 | 10.5 M to 10.5 M (-0.11 %) |
Nov 29 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.00 | 12,000 | 24,000 | 10,523,920 | 10.5 M to 10.5 M (-0.11 %) |
Nov 22 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.99 | 12,000 | 23,880 | 10,535,920 | 10.5 M to 10.5 M (-0.11 %) |
Nov 22 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.85 | 12,000 | 22,200 | 10,547,920 | 10.6 M to 10.5 M (-0.11 %) |
Nov 15 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.47 | 12,000 | 17,640 | 10,595,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 15 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.14 | 12,000 | 13,680 | 10,607,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 20 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.88 | 12,000 | 22,560 | 10,559,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 20 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.91 | 12,000 | 22,920 | 10,571,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 20 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.07 | 12,000 | 24,840 | 10,583,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 08 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.11 | 12,000 | 13,320 | 10,643,920 | 10.7 M to 10.6 M (-0.11 %) |
Nov 08 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.11 | 12,000 | 13,320 | 10,655,920 | 10.7 M to 10.7 M (-0.11 %) |
Nov 13 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.15 | 12,000 | 13,800 | 10,607,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 13 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.15 | 12,000 | 13,800 | 10,619,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 13 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.13 | 12,000 | 13,560 | 10,631,920 | 10.6 M to 10.6 M (-0.11 %) |
Nov 01 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.15 | 12,000 | 13,800 | 10,691,920 | 10.7 M to 10.7 M (-0.11 %) |
Nov 01 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.17 | 12,000 | 14,040 | 10,703,920 | 10.7 M to 10.7 M (-0.11 %) |
Nov 06 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.14 | 12,000 | 13,680 | 10,655,920 | 10.7 M to 10.7 M (-0.11 %) |
Nov 06 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.17 | 12,000 | 14,040 | 10,667,920 | 10.7 M to 10.7 M (-0.11 %) |
Nov 06 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.17 | 12,000 | 14,040 | 10,679,920 | 10.7 M to 10.7 M (-0.11 %) |
Oct 23 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | P | 1.38 | 12,000 | 16,560 | 10,763,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 23 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.39 | 12,000 | 16,680 | 10,775,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 23 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.41 | 12,000 | 16,920 | 10,787,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 31 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.18 | 12,000 | 14,160 | 10,715,920 | 10.7 M to 10.7 M (-0.11 %) |
Oct 31 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.23 | 12,000 | 14,760 | 10,727,920 | 10.7 M to 10.7 M (-0.11 %) |
Oct 31 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.29 | 12,000 | 15,480 | 10,739,920 | 10.8 M to 10.7 M (-0.11 %) |
Oct 21 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.45 | 12,000 | 17,400 | 10,799,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 21 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.45 | 12,000 | 17,400 | 10,811,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 25 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.33 | 12,000 | 15,960 | 10,751,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 25 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.37 | 12,000 | 16,440 | 10,763,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 16 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.49 | 12,000 | 17,880 | 10,787,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 16 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.49 | 12,000 | 17,880 | 10,799,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 16 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.49 | 12,000 | 17,880 | 10,811,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 15 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.50 | 12,000 | 18,000 | 10,823,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 15 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.52 | 12,000 | 18,240 | 10,835,920 | 10.8 M to 10.8 M (-0.11 %) |
Oct 09 2013 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.49 | 12,000 | 17,880 | 10,847,920 | 10.9 M to 10.8 M (-0.11 %) |